Vascular relaxing effects of bumetanide.
Bumetanide reduced basal tension of resting carotid arteries as well as tonic contraction elicited by 36 mM of KCl, KNO3 and 0.1 mM norepinephrine but had little effect on phasic response to norepinephrine and angiotensin II. Bumetanide was much more active against norepinephrine than KCl, KNO3 and its effect was not reduced by propranolol. These findings establish a distinction between bumetanide and the Ca antagonists, which do not affect basal tension but selectively inhibit potassium (K+) contracture. On the contrary, this compound resembles the nitrocompounds in that vascular relaxation does not require the integrity of endothelium but is abolished by methylene blue. These two common traits support the view that the increased synthesis of cyclic GMP secondary to guanylate cyclase activation may be directly involved in the vasodilating properties of the drug.
Copello
J
J
Instituto de Investigaciones Cardiológicas, Facultad de Medicina, Buenos Aires, Argentina.
Müller
A
A
Aquino
S
S
Villamil
M F
MF
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D002034:Bumetanide / Q000494:pharmacology*; D002339:Carotid Arteries / Q000187:drug effects; D004232:Diuretics / Q000494:pharmacology*; D004285:Dogs; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology; D066298:In Vitro Techniques; D008751:Methylene Blue / Q000494:pharmacology; D009126:Muscle Relaxation / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D014665:Vasodilator Agents
D004232:Diuretics; D014665:Vasodilator Agents; D002034:Bumetanide; D000804:Angiotensin II; D011188:Potassium; D008751:Methylene Blue; D009638:Norepinephrine